Health
First long-acting injectable HIV treatment appraised and approved by NICE – News-Medical.net
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited…
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England…
Continue Reading
-
Noosa News13 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General12 hours agoSingapore’s world-first sustainable flights tax will see some Australians pay more to travel
-
Noosa News13 hours agoBoy charged over E-Bike crash
-
General11 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
